DANBURY, Conn., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported its financial results for the second quarter of 2009. Compared with the second quarter of 2008, revenues increased sharply, operating expenses decreased by 11% and the Company's net loss was reduced significantly to $2.1 million, or $0.07 per share.
